Table 2. The risk score generated from the 3-mRNA signature as an independent indicator according to Cox proportional hazards regression model.
Factors | Subgroup | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|---|
Hazard ratio | 95% CI | p | Hazard ratio | 95% CI | p | ||
Age (year) | <50 | 1 | |||||
≥50, <60 | 0.8 | 0.4–1.5 | 0.516 | ||||
≥60, <70 | 1 | 0.5–1.8 | 0.925 | ||||
>70 | 1.6 | 0.9–3.0 | 0.125 | ||||
Gender | Male | 1 | |||||
Female | 1.1 | 0.7–1.6 | 0.722 | ||||
Race | White | 1 | |||||
Asian | 0.7 | 0.2–2.7 | 0.561 | ||||
Black or African American | 1.9 | 0.9–3.9 | 0.086 | ||||
Histologic grade | G1 | 1 | 1 | ||||
G2 | 1.7 | 0.9–3.2 | 0.121 | 1.3 | 0.7–2.6 | 0.405 | |
G3 | 2.2 | 1.1–4.5 | 0.035 | 1.8 | 0.9–3.8 | 0.111 | |
G4 | 0 | 0.0–Inf | 0.996 | 0 | 0.0–Inf | 0.996 | |
Pathological stage | Stage I | 1 | 1 | ||||
Stage II | 1.5 | 0.3–7.3 | 0.604 | 1 | 0.1–13.6 | 0.986 | |
Stage III | 3.4 | 0.8–14.4 | 0.1 | 2.3 | 0.2–27.8 | 0.518 | |
Stage IV | 5.1 | 1.2–20.8 | 0.024 | 1.9 | 0.1–23.8 | 0.6636 | |
Pathological T | T1 | 1 | 1 | ||||
T2 | 2.1 | 0.6–7.1 | 0.23 | 1.6 | 0.2–12.5 | 0.647 | |
T3 | 4.8 | 1.5–15.8 | 0.009 | 2.3 | 0.3–17.7 | 0.411 | |
T4 | 4.4 | 1.4–14.2 | 0.013 | 2.2 | 0.3–17.2 | 0.45 | |
Pathological N | N0 | 1 | 1 | ||||
N1 | 0.9 | 0.5–1.8 | 0.813 | 0.6 | 0.3–1.3 | 0.217 | |
N2 | 2.2 | 1.4–3.3 | <0.001 | 1.3 | 0.7–2.4 | 0.447 | |
N3 | 4.2 | 1.0–17.5 | 0.05 | 3.5 | 0.8–15.4 | 0.099 | |
Risk scores | Low risk | 1 | 1 | ||||
High risk | 2.3 | 1.5–3.6 | <0.001 | 1.9 | 1.2–2.9 | 0.004 |